Pages that link to "Q80104116"

The following pages link to Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection (Q80104116):

Displaying 27 items.

• Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer (Q26738587) (← links)
• Molecular biomarkers for the detection of metastatic colorectal cancer cells (Q27002450) (← links)
• Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study (Q33613616) (← links)
• Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen (Q33626102) (← links)
• Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients (Q34428780) (← links)
• Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer (Q34657343) (← links)
• Cancer micrometastases (Q34978121) (← links)
• A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer. (Q36152640) (← links)
• ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis (Q36175526) (← links)
• Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas (Q36840276) (← links)
• DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling (Q37190177) (← links)
• Methylation of serum SST gene is an independent prognostic marker in colorectal cancer (Q37298333) (← links)
• Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer (Q37593956) (← links)
• Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review (Q37730438) (← links)
• Predictive Markers of Colorectal Cancer Liver Metastases (Q37850818) (← links)
• Recent approaches to identifying biomarkers for high-risk stage II colon cancer (Q38041974) (← links)
• Clinical impact of minimal cancer cell detection in various colorectal cancer specimens (Q38254124) (← links)
• Time to Redefine the Role of Routine Combined-Modality Therapy for Invasive Stage-II/III Rectal Cancer? (Q41958603) (← links)
• Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies (Q42585781) (← links)
• Molecular biomarker panels for assessment of selenium status in rats (Q42931883) (← links)
• Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice (Q43262045) (← links)
• A highly sensitive telomerase activity assay that eliminates false-negative results caused by PCR inhibitors. (Q43689864) (← links)
• Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. (Q54203378) (← links)
• Recent advances in understanding the complexities of metastasis (Q58756849) (← links)
• T4N0 colon cancers should be treated like T3N1 disease (Q61804226) (← links)
• Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence (Q82930765) (← links)
• Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected (Q83663783) (← links)